Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease.

Sarah M Hartz Suzanne E Schindler Marissa L StreitzKrista L MoulderJessica T Mozersky Guoqiao WangChengjie XiongJohn C Morris

Published in: medRxiv : the preprint server for health sciences (2024)

Independence in ADLs can be related to CDR-SB and used to demonstrate the effect of AD treatments in extending the time of independent function, a meaningful outcome for patients and their families.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
mild cognitive impairment
patient reported outcomes